X4 Pharmaceuticals XFOR Q4 2025 Annual earnings
Reported March 17, 2026 · Before market open
Revenue$2.6MBeat by $835.0K
EPS-$0.22Beat by $0.14
Revenue estimate$1.7M
EPS estimate-$0.36
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$2.4M
EPS estimate-$0.19
Versus estimates
Revenue
Diluted EPS
Ask the moment X4 Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did X4 Pharmaceuticals report Q4 2025 earnings?
- X4 Pharmaceuticals (XFOR) reported Q4 2025 earnings on March 17, 2026 before market open.
- What were X4 Pharmaceuticals's Q4 2025 revenue and EPS?
- X4 Pharmaceuticals reported revenue of $2.6M and eps of $-0.22 for Q4 2025.
- Did X4 Pharmaceuticals beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $1.7M by $835.0K. EPS beat the consensus estimate of $-0.36 by $0.14.
- How did X4 Pharmaceuticals's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 79.1% from $1.4M a year earlier and eps grew 96.3% from $-6.01.
- Where can I find X4 Pharmaceuticals's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001501697-26-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.